New York, New York, Nov. 20, 2000 (Market News Publishing via COMTEX) --
ImmuLogic Pharmaceutical Corporation announced that it is making another
liquidation distribution of $.09 per share to all stockholders of record on
November 20, 2000. The ex-dividend date will be December 1, 2000. The Company
expects that this distribution will occur on or about December 2, 2000.
 
ImmuLogic's shareholders voted in August of 1999 to liquidate and dissolve the
Company. ImmuLogic is a Delaware corporation and Delaware law requires that the
Company remain in existence as a non-operating entity for at least three years
from the date the Company files a certificate of dissolution in Delaware and
maintain a certain level of assets to cover costs during the dissolution period.
During the dissolution period, the Company will attempt to convert its remaining
assets to cash as expeditiously as possible.
 
This press release contains forward-looking statements that involve a number of
risks and uncertainties, including risks and uncertainties that relate to the
liquidation of the Company's assets and satisfaction of its liabilities, and the
other risk factors detailed in the Company's Annual Report on Form 10-K for the
year ended December 31, 1999 and its Quarterly Reports on Form 10-Q for the
quarters ended March 31, 2000, June 30, 2000 and September 30, 2000.
 
 
 
 
-0-
 
 
 
TEL:  (781) 933-1772   ImmuLogic Pharmaceutical Corporation
 TEL:  (781) 933-1772   ImmuLogic Pharmaceutical Corporatio
                        J. Richard Crowley